A Presentation Summary of the Latest COVID-19 and Type 2 Diabetes Science

May 14, 2020

The science on COVID-19 and type 2 diabetes continues to evolve rapidly. If you haven’t been able to keep up to date on our latest COVID-19 coverage, don’t fret. Virta Medical Director Dr. Sarah Hallberg summarizes some key topics in this presentation, including:

  • Why it is difficult to get a definitive scientific understanding of COVID-19
  • Type 2 diabetes as a risk factor for COVID-19, including a systematic review and meta-analysis
  • Obesity as a risk factor for COVID-19, including an examination of cases of requiring invasive mechanical ventilation
  • Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes
  • The latest on outcomes associated with use of Angiotensin-converting Enzyme Inhibitors (ACEI) and Angiotensin II Receptor Blockers (ARB)

Some of this is technical content, and if you have questions, we'd love to hear from you.

Download PDF